View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tremelimumab 300 / Durvalumab 1500 - Durvalumab 1500, Hepatocellular Carcinoma, Cycle 2+
Protocol-ID: 2289 V1.0 (Mini), TREM300/DURV1500 - DURV1500, HCC, C2+Indication(s)
- Hepatocellular Carcinoma; ICD-10 C22.0
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 22.03.2023